What is the current price and volume for ALDEI.PA stock?

ALDEI.PA stock trades intraday near **€0.03** with volume at **13,014,939** shares on EURONEXT. Average volume is roughly **5,992,347**, so today’s activity is about 2.17 times normal, raising short-term volatility.

What does Meyka AI say about ALDEI.PA stock?

Meyka AI rates ALDEI.PA **61.07/100**, Grade **B**, Suggestion **HOLD**. The score mixes benchmark, sector and company metrics. The model projects **€0.05** in 12 months, but forecasts are projections, not guarantees.

What are the main risks for ALDEI.PA stock traders?

Main risks for ALDEI.PA stock include limited liquidity, large intraday swings, negative EPS (**-0.24**), potential dilution and clinical trial setbacks. These factors make position sizing and stop rules essential for intraday trades.

Is there a published analyst price target for ALDEI.PA stock?

There is no broad analyst consensus or published price target for ALDEI.PA stock. Coverage is thin; Meyka AI supplies a model projection of **€0.05**, while conservative and optimistic bands should guide risk-adjusted positions.

EU Stocks

ALDEI.PA Deinove SA EURONEXT €0.03 16 Jan 2026: volume spike guides intraday outlook

ByHuzaifa Zahoor January 16, 2026January 16, 2026

The ALDEI.PA stock is trading at €0.03 on EURONEXT in Europe on 16 Jan 2026, led by a surge in intraday volume of 13,014,939 shares. Traders are reacting to biotech pipeline updates and the stock’s extreme microcap profile. Volume is more than twice the average, which has amplified intraday volatility. We track price action, key ratios, Meyka AI grade and a model forecast to frame near-term opportunities and risks for Deinove SA.